SOURCE 3 Registry: Design and 30-Day Results of the European Post Approval Registry of the Latest Generation of the Sapien 3TM Transcatheter Heart Valve.
CONCLUSIONS: -Results from the SOURCE 3 Registry demonstrate contemporary European trends and good outcomes of TAVI in daily practice when using this third generation TAVI device.
PMID: 28104716 [PubMed - as supplied by publisher]
Source: Circulation - Category: Cardiology Authors: Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G, Zamorano JL, Vahanian A Tags: Circulation Source Type: research
More News: Academia | Bleeding | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Chronic Obstructive Pulmonary | Diabetes | Endocrinology | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Stroke | Study